We are monitoring the impact of COVID-19 on Prostate Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1536
Share on
Share on

Global Prostate Cancer Market Size, Share, Trends and Growth Analysis Report – Segmented By Diagnostic Techniques, Chemotherapy and Region - Industry Size, Share, Growth, Trends & Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1536
Pages: 175

Global Prostate Cancer Market Size (2020 to 2025)

As per our report, the global prostate cancer market size is estimated to worth USD 57.55 billion in 2020. This value is forecasted to be growing at a CAGR of 9.5% and will reach USD 90.6 billion by 2025.

The prostate cancer market has a high demand for novel drugs that concentrate on unmet needs, such as improved survival time, less toxicity, better progression-free survival, improved effectiveness, and lesser cost.

Prostate cancer is a progression of cancer in the prostate, a gland present in the male reproductive system. The cancer cells might reach the other parts of the body, viz. the bones and lymph nodes from the prostate. In the later stages of cancer, it can cause difficulty in urination, blood in the urine, etc. Prostate cancer is most of the time diagnosed by biopsy.

MARKET DRIVERS:

The growing number of novel drugs expected to get launched in the short-term future and the rising old-age male population drive the growth of the global prostate cancer market.

Altering lifestyle, technological advancements in researching for new techniques to fight prostate cancer, increase in the funding in both the public and private sectors in drug advancement are some of the key reasons driving the growth of the global prostate cancer market.

The prostate cancer market is further anticipated to expand during the forecast period due to growth opportunities such as untapped market potential due to unmet medical treatment requirements, growing awareness among people, and advancements in the healthcare field. Further, patent expiration of significant drugs like Zytiga is likely to provide lucrative opportunities during the forecast period.

MARKET RESTRAINTS:

The major restraints that challenge the growth of the Prostate Cancer Market are ever-changing reimbursement policies, extending the time span of treatment, the expensive nature of combination therapies, and managing the life cycle of drugs. The shortage of skilled people in monitoring the equipment in laboratories is slowly degrading the market demand. Besides, government bodies' frequent changes in the economic strategies are hindering the growth rate of the market.

Impact of COVID-19 on the global prostate cancer market:

The coronavirus (COVID-19) pandemic has disrupted the world and has affected almost every sector in every corner. The crisis has additionally added an excess layer of pressure or burden in many people. Treating patients efficiently over the pandemic crisis has become a significant challenge for clinicians. Prostate cancer patients are at mounting risk of coronavirus infection along with illness and deaths if infected. Prostate cancer services are on hold due to the changing medical and surgical importance. Once accurately organized and to reduce the spread of the virus, prostate cancer patients can observe telemedicine, establish lifestyle changes, and maintain social distancing. Prostate cancer patients need to be followed up remotely unless and until the COVID 19 pandemic sets right. Prostate cancer patients have amplified occurrences and mortality from COVID 19 infection due to gender, age, and propensity factors.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Diagnostic Techniques, Surgery, Radiation Therapy, Chemotherapy and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global prostate cancer market has been segmented and sub-segmented based on diagnostic techniques, surgery, radiation therapy, chemotherapy, and region.

Prostate Cancer Market – By Diagnostic Techniques:

  • Digital Rectal Exam (DRE)
  • Prostate-Specific Antigen Test (PSA)

Based on the diagnostic technique, the Prostate-Specific Antigen Test (PSA) segment is expected to grow rapidly during the forecast period. The PSA test is to diminish the possibility of death from cancer. The amplifying research and development activities are accompanying the booming ubiquity of castrate-resistant prostate cancer. The factors above foster market growth. 

Prostate Cancer Market – By Surgery:

  • Radical Prostatectomy
  • Orchidectomy
  • Trans Urethral Resection (TUR)

Prostate Cancer Market – By Radiation Therapy:

  • External Beam Radiation Therapy
    • 3D Conformal Radiation Therapy
    • Intensity Modulated Radiation Therapy
    • Stereotactic Body Radiation Therapy
    • Proton Beam Radiation Therapy
  • Brachytherapy
    • Permanent Brachytherapy
    • Temporary Brachytherapy

Prostate Cancer Market – By Chemotherapy:

  • Docetaxel
  • Etoposide
  • Vinblastine
  • Carboplatin
  • Vinorelbine

Prostate Cancer Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the Asia Pacific is ruling the prostate cancer market due to factors such as increasing economies of the developing nations, rising youth population, rising prostate cancer cases in older people, increasing focus on the promotion of preventive drugs and research initiatives.

The North American market segment has contributed a prominent share in recent years and is expected to grow exponentially during the forecast period.

Latin American regions are estimated to record the highest CAGR during the forecast period.

KEY MARKET PARTICIPANTS:

Prominent companies dominating the global prostate cancer market profiled in the report are Sanofi S.A., GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech.

RECENT MARKET DEVELOPMENTS:

  • Pfizer Company completed the Array Biopharma acquisition in June 2019; Pfizer is looking forward to expanding its product portfolio and research operations regarding prostate cancer with the biotech giant Array Biopharma.
  • In September 2019, The National Institute of Health had revealed that prostate cancer screens might turn to biomarkers in semen. The edible and hub have collaborated to research extracellular miRNAs. As the research outcomes, they concluded that semen exosome miRNA-based biomarkers do have the potential to improve the diagnosis of prostate cancer. 
  • Johnson and Johnson's company has developed a drug called Erleada for treating metastatic hormone-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer, which has got approved by the FDA in February 2018.
  • A company based in the U.K has launched a new advanced ultrasound imaging technique in 2018; the technique is integrated with artificial intelligence to enhance prostate cancer detection.
  • Mayroy SA Company demerged from Ispen Company in December 2019. 
  • In 2019, Profound Medical Inc. developed a TULSA tool (MRI-guided transurethral ultrasound ablation) for treating prostate cancer and enlarged prostate at high accuracy without any side effects.
  • Prostate cancer can be diagnosed accurately more shortly and simply by conducting urine tests at home, and this was confirmed by the Pilot Study, which has been conducted very recently.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Diagnostic Techniques           

                                5.1.1 Introduction

                                5.1.2 Digital Rectal Exam (DRE)

                                5.1.3 Prostate Specific Antigen Test (PSA)

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product

                                5.1.6 Market Share Analysis, By Product

                5.2 Surgery        

                                5.2.1 Introduction

                                5.2.2 Radical Prostatectomy

                                5.2.3 Orchidectomy

                                5.2.4 Trans Urethral Resection (TUR)

                                5.2.5 Y-o-Y Growth Analysis, By Type

                                5.2.6 Market Attractiveness Analysis, By Type

                                5.2.7 Market Share Analysis, By Type

                5.3 Radiation Therapy   

                                5.3.1 Introduction

                                5.3.2 External Beam Radiation Therapy

                                5.3.3 Brachytherapy

                                5.3.4 Y-o-Y Growth Analysis, By Application

                                5.3.5 Market Attractiveness Analysis, By Application

                                5.3.6 Market Share Analysis, By Application

                5.4 Chemotherapy         

                                5.4.1 Introduction

                                5.4.2 Docetaxel

                                5.4.3 Etoposide

                                5.4.4 Vinblastine

                                5.4.5 Carboplatin

                                5.4.6 Vinorelbine

                                5.4.7 Y-o-Y Growth Analysis, By Disease Indications

                                5.4.8 Market Attractiveness Analysis, By Disease Indications

                                5.4.9 Market Share Analysis, By Disease Indications

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                                6.1.4 Market Attractiveness Analysis

                                6.1.5 Market Share Analysis               

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Sanofi S.A    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 GlaxoSmithKline      

                8.3 AstraZeneca

                8.4 AbbVie         

                8.5 Varian Medical Systems        

                8.6 Elekta           

                8.7 Theragenics

                8.8 Pfizer            

                8.9 Novartis       

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Prostate Cancer Market, By Region, From 2020 to 2025
  2. Global Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  3. Global Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  4. Global Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  5. Global Prostate Cancer Market, By Surgery, From 2020 to 2025
  6. Global Radical Prostatectomy Market, By Region, From 2020 to 2025
  7. Global Orchidectomy Market, By Region, From 2020 to 2025
  8. Global Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  9. Global Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  10. Global External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  11. Global Brachytherapy Market, By Region, From 2020 to 2025
  12. Global Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  13. Global Docetaxel Market, By Region, From 2020 to 2025
  14. Global Etoposide Market, By Region, From 2020 to 2025
  15. Global Vinblastine Market, By Region, From 2020 to 2025
  16. Global Carboplatin Market, By Region, From 2020 to 2025
  17. Global Vinorelbine Market, By Region, From 2020 to 2025
  18. Global Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  19. Global 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  20. Global Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  21. Global Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  22. Global Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  23. Global Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  24. Global Permanent Brachytherapy Market, By Region, From 2020 to 2025
  25. Global Temporary Brachytherapy Market, By Region, From 2020 to 2025
  26. North America Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  27. North America Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  28. North America Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  29. North America Prostate Cancer Market, By Surgery, From 2020 to 2025
  30. North America Radical Prostatectomy Market, By Region, From 2020 to 2025
  31. North America Orchidectomy Market, By Region, From 2020 to 2025
  32. North America Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  33. North America Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  34. North America External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  35. North America Brachytherapy Market, By Region, From 2020 to 2025
  36. North America Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  37. North America Docetaxel Market, By Region, From 2020 to 2025
  38. North America Etoposide Market, By Region, From 2020 to 2025
  39. North America Vinblastine Market, By Region, From 2020 to 2025
  40. North America Carboplatin Market, By Region, From 2020 to 2025
  41. North America Vinorelbine Market, By Region, From 2020 to 2025
  42. United States Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  43. United States Prostate Cancer Market, By Surgery, From 2020 to 2025
  44. United States Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  45. United States Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  46. Canada Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  47. Canada Prostate Cancer Market, By Surgery, From 2020 to 2025
  48. Canada Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  49. Canada Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  50. North America Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  51. North America 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  52. North America Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  53. North America Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  54. North America Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  55. United States Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  56. Canada Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  57. North America Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  58. North America Permanent Brachytherapy Market, By Region, From 2020 to 2025
  59. North America Temporary Brachytherapy Market, By Region, From 2020 to 2025
  60. United States Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  61. Canada Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  62. Europe Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  63. Europe Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  64. Europe Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  65. Europe Prostate Cancer Market, By Surgery, From 2020 to 2025
  66. Europe Radical Prostatectomy Market, By Region, From 2020 to 2025
  67. Europe Orchidectomy Market, By Region, From 2020 to 2025
  68. Europe Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  69. Europe Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  70. Europe External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  71. Europe Brachytherapy Market, By Region, From 2020 to 2025
  72. Europe Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  73. Europe Docetaxel Market, By Region, From 2020 to 2025
  74. Europe Etoposide Market, By Region, From 2020 to 2025
  75. Europe Vinblastine Market, By Region, From 2020 to 2025
  76. Europe Carboplatin Market, By Region, From 2020 to 2025
  77. Europe Vinorelbine Market, By Region, From 2020 to 2025
  78. U.K. Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  79. U.K. Prostate Cancer Market, By Surgery, From 2020 to 2025
  80. U.K. Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  81. U.K. Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  82. Germany Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  83. Germany Prostate Cancer Market, By Surgery, From 2020 to 2025
  84. Germany Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  85. Germany Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  86. France Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  87. France Prostate Cancer Market, By Surgery, From 2020 to 2025
  88. France Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  89. France Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  90. Italy Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  91. Italy Prostate Cancer Market, By Surgery, From 2020 to 2025
  92. Italy Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  93. Italy Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  94. Spain Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  95. Spain Prostate Cancer Market, By Surgery, From 2020 to 2025
  96. Spain Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  97. Spain Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  98. Europe Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  99. Europe 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  100. Europe Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  101. Europe Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  102. Europe Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  103. U.K. Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  104. Germany Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  105. France Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  106. Italy Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  107. Spain Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  108. Europe Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  109. Europe Permanent Brachytherapy Market, By Region, From 2020 to 2025
  110. Europe Temporary Brachytherapy Market, By Region, From 2020 to 2025
  111. U.K. Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  112. Germany Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  113. France Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  114. Italy Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  115. Spain Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  116. Asia-Pacific Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  117. Asia-Pacific Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  118. Asia-Pacific Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  119. Asia-Pacific Prostate Cancer Market, By Surgery, From 2020 to 2025
  120. Asia-Pacific Radical Prostatectomy Market, By Region, From 2020 to 2025
  121. Asia-Pacific Orchidectomy Market, By Region, From 2020 to 2025
  122. Asia-Pacific Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  123. Asia-Pacific Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  124. Asia-Pacific External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  125. Asia-Pacific Brachytherapy Market, By Region, From 2020 to 2025
  126. Asia-Pacific Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  127. Asia-Pacific Docetaxel Market, By Region, From 2020 to 2025
  128. Asia-Pacific Etoposide Market, By Region, From 2020 to 2025
  129. Asia-Pacific Vinblastine Market, By Region, From 2020 to 2025
  130. Asia-Pacific Carboplatin Market, By Region, From 2020 to 2025
  131. Asia-Pacific Vinorelbine Market, By Region, From 2020 to 2025
  132. Japan Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  133. Japan Prostate Cancer Market, By Surgery, From 2020 to 2025
  134. Japan Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  135. Japan Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  136. China Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  137. China Prostate Cancer Market, By Surgery, From 2020 to 2025
  138. China Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  139. China Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  140. India Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  141. India Prostate Cancer Market, By Surgery, From 2020 to 2025
  142. India Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  143. India Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  144. Australia Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  145. Australia Prostate Cancer Market, By Surgery, From 2020 to 2025
  146. Australia Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  147. Australia Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  148. South Korea Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  149. South Korea Prostate Cancer Market, By Surgery, From 2020 to 2025
  150. South Korea Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  151. South Korea Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  152. Asia-Pacific Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  153. Asia-Pacific 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  154. Asia-Pacific Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  155. Asia-Pacific Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  156. Asia-Pacific Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  157. Japan Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  158. China Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  159. India Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  160. Australia Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  161. Asia-Pacific Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  162. Asia-Pacific Permanent Brachytherapy Market, By Region, From 2020 to 2025
  163. Asia-Pacific Temporary Brachytherapy Market, By Region, From 2020 to 2025
  164. Japan Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  165. China Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  166. India Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  167. Australia Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  168. Latin America Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  169. Latin America Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  170. Latin America Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  171. Latin America Prostate Cancer Market, By Surgery, From 2020 to 2025
  172. Latin America Radical Prostatectomy Market, By Region, From 2020 to 2025
  173. Latin America Orchidectomy Market, By Region, From 2020 to 2025
  174. Latin America Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  175. Latin America Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  176. Latin America External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  177. Latin America Brachytherapy Market, By Region, From 2020 to 2025
  178. Latin America Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  179. Latin America Docetaxel Market, By Region, From 2020 to 2025
  180. Latin America Etoposide Market, By Region, From 2020 to 2025
  181. Latin America Vinblastine Market, By Region, From 2020 to 2025
  182. Latin America Carboplatin Market, By Region, From 2020 to 2025
  183. Latin America Vinorelbine Market, By Region, From 2020 to 2025
  184. Brazil Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  185. Brazil Prostate Cancer Market, By Surgery, From 2020 to 2025
  186. Brazil Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  187. Brazil Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  188. Argentina Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  189. Argentina Prostate Cancer Market, By Surgery, From 2020 to 2025
  190. Argentina Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  191. Argentina Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  192. Mexico Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  193. Mexico Prostate Cancer Market, By Surgery, From 2020 to 2025
  194. Mexico Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  195. Mexico Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  196. Rest of Latin America Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  197. Rest of Latin America Prostate Cancer Market, By Surgery, From 2020 to 2025
  198. Rest of Latin America Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  199. Rest of Latin America Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  200. Latin America Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  201. Latin America 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  202. Latin America Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  203. Latin America Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  204. Latin America Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  205. Brazil Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  206. Argentina Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  207. Mexico Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  208. Latin America Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  209. Latin America Permanent Brachytherapy Market, By Region, From 2020 to 2025
  210. Latin America Temporary Brachytherapy Market, By Region, From 2020 to 2025
  211. Brazil Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  212. Argentina Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  213. Mexico Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  214. Middle East & Africa Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  215. Middle East & Africa Digital Rectal Exam (DRE) Market, By Region, From 2020 to 2025
  216. Middle East & Africa Prostate Specific Antigen Test (PSA) Market, By Region, From 2020 to 2025
  217. Middle East & Africa Prostate Cancer Market, By Surgery, From 2020 to 2025
  218. Middle East & Africa Radical Prostatectomy Market, By Region, From 2020 to 2025
  219. Middle East & Africa Orchidectomy Market, By Region, From 2020 to 2025
  220. Middle East & Africa Trans Urethral Resection (TUR) Market, By Region, From 2020 to 2025
  221. Middle East & Africa Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  222. Middle East & Africa External Beam Radiation Therapy Market, By Region, From 2020 to 2025
  223. Middle East & Africa Brachytherapy Market, By Region, From 2020 to 2025
  224. Middle East & Africa Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  225. Middle East & Africa Docetaxel Market, By Region, From 2020 to 2025
  226. Middle East & Africa Etoposide Market, By Region, From 2020 to 2025
  227. Middle East & Africa Vinblastine Market, By Region, From 2020 to 2025
  228. Middle East & Africa Carboplatin Market, By Region, From 2020 to 2025
  229. Middle East & Africa Vinorelbine Market, By Region, From 2020 to 2025
  230. Middle East Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  231. Middle East Prostate Cancer Market, By Surgery, From 2020 to 2025
  232. Middle East Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  233. Middle East Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  234. Africa Prostate Cancer Market, By Diagnostic Techniques , From 2020 to 2025
  235. Africa Prostate Cancer Market, By Surgery, From 2020 to 2025
  236. Africa Prostate Cancer Market, By Radiation Therapy, From 2020 to 2025
  237. Africa Prostate Cancer Market, By ChemoTherapy, From 2020 to 2025
  238. Middle East & Africa Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  239. Middle East & Africa 3D Conformal Radiation Therapy Market, By Region, From 2020 to 2025
  240. Middle East & Africa Intensity Modulated Radiation Therapy Market, By Region, From 2020 to 2025
  241. Middle East & Africa Stereotactic Body Radiation Therapy Market, By Region, From 2020 to 2025
  242. Middle East & Africa Proton Beam Radiation Therapy Market, By Region, From 2020 to 2025
  243. Middle East Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  244. Africa Prostate Cancer Market, By External Beam Radiation Therapy, From 2020 to 2025
  245. Middle East & Africa Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  246. Middle East & Africa Permanent Brachytherapy Market, By Region, From 2020 to 2025
  247. Middle East & Africa Temporary Brachytherapy Market, By Region, From 2020 to 2025
  248. Middle East Prostate Cancer Market, By Brachytherapy, From 2020 to 2025
  249. Africa Prostate Cancer Market, By Brachytherapy, From 2020 to 2025

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample